Matthias Schmidt

Matthias Schmidt

Auto-generated profile, based on publicly available information

Matthias Schmidt

Institute of Protein Biochemistry, Ulm University, Ulm, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
FLFalk Liberta
Falk Liberta
SLSarah Loerch
Sarah Loerch
MRMatthies Rennegarbe
Matthies Rennegarbe
ASAngelika Schierhorn
Angelika Schierhorn
PWPer Westermark
Per Westermark
MSMatthias Schmidt
Matthias Schmidt
Systemic AA amyloidosis is a worldwide occurring protein misfolding disease of humans and animals. It arises from the formation of amyloid fibrils from the acute phase protein serum amyloid A. Here, we report the purification and electron cryo-microscopy analysis of amyloid fibrils from a mouse and a human patient with systemic AA amyloidosis. The obtained resolutions are 3.0 Å and 2.7 Å for the murine and human fibril, respectively. The two fibrils differ in fundamental properties, such as presence of right-hand or left-hand twisted cross-β sheets and overall fold of the fibril proteins. Yet, both proteins adopt highly similar β-arch conformations within the N-terminal ~21 residues. Our data demonstrate the importance of the fibril protein N-terminus for the stability of the analyzed amyloid fibril morphologies and suggest strategies of combating this disease by interfering with specific fibril polymorphs.

8 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LRLynn Radamaker
Lynn Radamaker
JBJulian Baur
Julian Baur
SHStefanie Huhn
Stefanie Huhn
CHChristian Haupt
Christian Haupt
UHUte Hegenbart
Ute Hegenbart
MFMarcus Fändrich
Marcus Fändrich
Systemic AL amyloidosis is a debilitating and potentially fatal disease that arises from the misfolding and fibrillation of immunoglobulin light chains (LCs). The disease is patient-specific with essentially each patient possessing a unique LC sequence. In this study, we present two ex vivo fibril structures of a λ3 LC. The fibrils were extracted from the explanted heart of a patient (FOR005) and consist of 115-residue fibril proteins, mainly from the LC variable domain. The fibril structures imply that a 180° rotation around the disulfide bond and a major unfolding step are necessary for fibrils to form. The two fibril structures show highly similar fibril protein folds, differing in only a 12-residue segment. Remarkably, the two structures do not represent separate fibril morphologies, as they can co-exist at different z-axial positions within the same fibril. Our data imply the presence of structural breaks at the interface of the two structural forms.

5 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
LRLynn Radamaker
Lynn Radamaker
SKSara Karimi-Farsijani
Sara Karimi-Farsijani
GAGiada Andreotti
Giada Andreotti
JBJulian Baur
Julian Baur
Mathias NeumannMathias Neumann
Mathias Neumann
MFMarcus Fändrich
Marcus Fändrich
Systemic AL amyloidosis is a rare disease that is caused by the misfolding of immunoglobulin light chains (LCs). Potential drivers of amyloid formation in this disease are post-translational modifications (PTMs) and the mutational changes that are inserted into the LCs by somatic hypermutation. Here we present the cryo electron microscopy (cryo-EM) structure of an ex vivo λ1-AL amyloid fibril whose deposits disrupt the ordered cardiomyocyte structure in the heart. The fibril protein contains six mutational changes compared to the germ line and three PTMs (disulfide bond, N-glycosylation and pyroglutamylation). Our data imply that the disulfide bond, glycosylation and mutational changes contribute to determining the fibril protein fold and help to generate a fibril morphology that is able to withstand proteolytic degradation inside the body.

12 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAkanksha Bansal
Akanksha Bansal
MSMatthias Schmidt
Matthias Schmidt
MRMatthies Rennegarbe
Matthies Rennegarbe
CHChristian Haupt
Christian Haupt
FLFalk Liberta
Falk Liberta
MFMarcus Fändrich
Marcus Fändrich
Systemic AA amyloidosis is a world-wide occurring protein misfolding disease of humans and animals. It arises from the formation of amyloid fibrils from serum amyloid A (SAA) protein. Using cryo electron microscopy we here show that amyloid fibrils which were purified from AA amyloidotic mice are structurally different from fibrils formed from recombinant SAA protein in vitro. Ex vivo amyloid fibrils consist of fibril proteins that contain more residues within their ordered parts and possess a higher β-sheet content than in vitro fibril proteins. They are also more resistant to proteolysis than their in vitro formed counterparts. These data suggest that pathogenic amyloid fibrils may originate from proteolytic selection, allowing specific fibril morphologies to proliferate and to cause damage to the surrounding tissue.

27 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMaximilian Steinebrei
Maximilian Steinebrei
JGJuliane Gottwald
Juliane Gottwald
JBJulian Baur
Julian Baur
CRChristoph Röcken
Christoph Röcken
UHUte Hegenbart
Ute Hegenbart
MSMatthias Schmidt
Matthias Schmidt
Wild type transthyretin-derived amyloid (ATTRwt) is the major component of non-hereditary transthyretin amyloidosis. Its accumulation in the heart of elderly patients is life threatening. A variety of genetic variants of transthyretin can lead to hereditary transthyretin amyloidosis, which shows different clinical symptoms, like age of onset and pattern of organ involvement. However, in the case of non-hereditary transthyretin amyloidosis ATTRwt fibril deposits are located primarily in heart tissue. In this structural study we analyzed ATTRwt amyloid fibrils from the heart of a patient with non-hereditary transthyretin amyloidosis. We present a 2.78 Å reconstructed density map of these ATTRwt fibrils using cryo electron microscopy and compare it with previously published V30M variants of ATTR fibrils extracted from heart and eye of different patients. All structures show a remarkably similar spearhead like shape in their cross section, formed by the same N- and C-terminal fragments of transthyretin with some minor differences. This demonstrates common features for ATTR fibrils despite differences in mutations and patients.

12 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKartikay Sharma
Kartikay Sharma
FSFabian Stockert
Fabian Stockert
JSJayakrishna Shenoy
Jayakrishna Shenoy
MBMélanie Berbon
Mélanie Berbon
MAMuhammed Bilal Abdul-Shukkoor
Muhammed Bilal Abdul-Shukkoor
MFMarcus Fändrich
Marcus Fändrich
The transactive response DNA-binding protein-43 (TDP-43) is a multi-facet protein involved in phase separation, RNA-binding, and alternative splicing. In the context of neurodegenerative diseases, abnormal aggregation of TDP-43 has been linked to amyotrophic lateral sclerosis and frontotemporal lobar degeneration through the aggregation of its C-terminal domain. Here, we report a cryo-electron microscopy (cryo-EM)-based structural characterization of TDP-43 fibrils obtained from the full-length protein. We find that the fibrils are polymorphic and contain three different amyloid structures. The structures differ in the number and relative orientation of the protofilaments, although they share a similar fold containing an amyloid key motif. The observed fibril structures differ from previously described conformations of TDP-43 fibrils and help to better understand the structural landscape of the amyloid fibril structures derived from this protein.